RE: Another good RNS11 Feb 2026 09:07
Now the confusion on L2 appears to be resolved, it appears the market is appreciative of Aptamers RNS market progress update. Well done all at Aptamer and unless Fierce Bio have already advised the US market of the added accuracy benefitting from Aptamers involvement, they will hopefully increase their uptake on the newly launched service....Good luck all.